تجاوز إلى المحتوى الرئيسي
Safety-Related Labeling Changes
Because of the known effects of prostaglandin-inhibiting drugs on the fetal cardiovascular system (closure of the ductus arteriosus), the use of ACUVAIL during late pregnancy should be avoided.
Trade Name
Acuvail Ophthalmic Solution
Updated Section
4.6 Fertility, pregnancy and lactation
Month
Feb,2026